University of Washington / World Health Organization / office of New Drugs / office of Surveillance and Epidemiology / HOUSE OF REPRESENTATIVES / Committee on Oversight and Government Reform / Center for Health Studies / HOUSE OF REPRESENTATIVES ONE HUNDRED TENTH CONGRESS FIRST SESSION / Senate / FDA / Food and Drug Administration / Committee on Oversight / University of North Carolina School of Medicine / Congress / U.S. GOVERNMENT PRINTING OFFICE WASHINGTON / Cardiovascular Health Research Unit / GlaxoSmithKline / /
Person
Ellen Brown / ELEANOR HOLMES NORTON / ELIJAH E. CUMMINGS / Larry Halloran / CAROLYN B. MALONEY / KATIE FDA / Rachel Sher / Deng / JIM COOPER / Sarah Despres / John K. Jenkins / DARRELL E. ISSA / PAUL E. KANJORSKI / TODD RUSSELL PLATTS / CHRISTOPHER S. MURPHY / CHRIS CANNON / DAN BURTON / JOHN P. SARBANES / JOHN F. TIERNEY / TOM DAVIS / PETER WELCH / LACY CLAY / Victoria Proctor / PATRICK T. MCHENRY / Keith Ausbrook / JIM JORDAN / MICHAEL R. TURNER / Brian McNicoll / Susie Schulte / Andy Schneider / KATIE CONTENTS / JOHN M. MCHUGH / Jennifer Safavian / John B. Buse / Teresa Coufal / BRIAN HIGGINS / BRIAN P. BILBRAY / LYNN A. WESTMORELAND / Bruce M. Psaty / John Cuaderes / Karen Lightfoot / JOHN J. DUNCAN / PAUL W. HODES / Patrick Lyden / Karen Nelson / William Ragland / Steven / Brian Storm / DANNY K. DAVIS / STEPHEN F. LYNCH / MARK E. SOUDER / Kristen Amerling / Steve Cha / Benjamin Chance / BILL SALI / Leneal Scott / DENNIS J. KUCINICH / JOHN A. YARMUTH / HENRY A. WAXMAN / KENNY MARCHANT / BRUCE L. BRALEY / DAVID MARIN / PHIL BARNETT / TOM LANTOS / DIANE E. WATSON / Anne Marie Turner / EARLEY GREEN / CHRIS VAN HOLLEN / VIRGINIA FOXX / PHIL SCHILIRO / CHRISTOPHER SHAYS / Molly Gulland / BETTY MCCOLLUM / Yamada / / /
Position
Chief Clerk / chairman / Department of Cardiovascular Medicine / parliamentarian and member services coordinator / minority communications director / Staff Director / chief information officer / Superintendent / minority general counsel / senior health counsel / staff director and chief counsel / professor / senior investigator and policy advisor / Chief of Staff / Representative / professor of medicine / Epidemiology and Health Services / investigator / deputy staff director / counsel / chief health counsel / assistant communications director / minority chief counsel / co-director / press assistant / general counsel / health policy director / minority counsel / deputy clerk / chairman / research and development / Chairman / minority clerk / director / Commissioner / information systems manager / communications director and senior policy advisor / Minority Staff Director / Republican member / minority legislative director and senior policy counsel / /
Product
AVANDIA / /
ProgrammingLanguage
DC / /
ProvinceOrState
Virginia / Washington / California / Idaho / BRIAN P. BILBRAY / Kentucky / Vermont / Illinois / /
FDA’S ROLE IN THE EVALUATION OF AVANDIA’S SAFETY HEARING BEFORE THE